← All Sponsors
SPONSOR

Sichuan Kelun Pharmaceutical Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Healthy Volunteers
NCT07143318 Phase 1
Recruiting

First-in-Human Single and Multiple Dose of KLA578-1 for Injection

Healthy Volunteers
China View Trial →